Carl P. Bergstrom

Person

Madison, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
- Patent number 8,513,253
- Issue date Aug 20, 2013
- Bristol-Myers Squibb Company
- Michael F. Parker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of hepatitis C
- Patent number 8,143,243
- Issue date Mar 27, 2012
- Bristol-Myers Squibb Company
- Scott W. Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of hepatitis C
- Patent number 8,133,884
- Issue date Mar 13, 2012
- Bristol-Myers Squibb Company
- Scott W. Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
- Patent number 7,786,122
- Issue date Aug 31, 2010
- Bristol-Myers Squibb Company
- Michael F. Parker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of hepatitis C
- Patent number 7,652,004
- Issue date Jan 26, 2010
- Bristol-Myers Squibb Company
- Scott W. Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of hepatitis C
- Patent number 7,642,251
- Issue date Jan 5, 2010
- Bristol-Myers Squibb Company
- Carl P. Bergstrom
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
- Patent number 7,521,441
- Issue date Apr 21, 2009
- Bristol-Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indolobenzazepine HCV NS5B inhibitors
- Patent number 7,473,688
- Issue date Jan 6, 2009
- Bristol-Myers Squibb Company
- Carl P. Bergstrom
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
- Patent number 7,456,167
- Issue date Nov 25, 2008
- Bristol-Myers Squibb Company
- Carl P. Bergstrom
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
HCV NS5B inhibitors
- Patent number 7,456,165
- Issue date Nov 25, 2008
- Bristol-Myers Squibb Company
- Carl P. Bergstrom
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of HCV replication
- Patent number 7,348,425
- Issue date Mar 25, 2008
- Bristol-Myers Squibb Company
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
- Patent number 7,300,936
- Issue date Nov 27, 2007
- Bristol-Myers Squibb Company
- Michael F. Parker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of HCV replication
- Patent number 7,153,848
- Issue date Dec 26, 2006
- Bristol-Myers Squibb Company
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfonamide compounds and uses thereof
- Patent number 6,967,196
- Issue date Nov 22, 2005
- Bristol-Myers Squibb Company
- David W. Smith
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Alpha-(N-Sulfonamido)Acetamide Derivatives as Beta-Amyloid Inhibitors
- Publication number 20110105485
- Publication date May 5, 2011
- Bristol -Myers Squibb Company
- Michael F. Parker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20090280083
- Publication date Nov 12, 2009
- Bristol -Myers Squibb Company
- Scott W. Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20090275561
- Publication date Nov 5, 2009
- Bristol -Myers Squibb Company
- Scott W. Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20090074715
- Publication date Mar 19, 2009
- Bristol -Myers Squibb Company
- Scott W. Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20090042860
- Publication date Feb 12, 2009
- Bristol -Myers Squibb Company
- Carl P. Bergstrom
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALPHA-(N-SULFONAMIDO)ACETAMIDE DERIVATIVES AS BETA-AMYLOID INHIBITORS
- Publication number 20080085894
- Publication date Apr 10, 2008
- Bristol -Myers Squibb Company
- Michael F. Parker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
- Publication number 20070275947
- Publication date Nov 29, 2007
- Bristol -Myers Squibb Company
- Carl P. Bergstrom
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
- Publication number 20070270406
- Publication date Nov 22, 2007
- Bristol -Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HCV NS5B Inhibitors
- Publication number 20070185083
- Publication date Aug 9, 2007
- Bristol -Myers Squibb Company
- Carl P. Bergstrom
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Indolobenzazepine HCV NS5B inhibitors
- Publication number 20070078122
- Publication date Apr 5, 2007
- Bristol -Myers Squibb Company
- Carl P. Bergstrom
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of HCV replication
- Publication number 20060166964
- Publication date Jul 27, 2006
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of HCV replication
- Publication number 20060046983
- Publication date Mar 2, 2006
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Alpha-(N-sulfonamido)acetamide derivatives as beta-amyloid inhibitors
- Publication number 20040127494
- Publication date Jul 1, 2004
- Michael F. Parker
- C07 - ORGANIC CHEMISTRY

Carl P. Bergstrom

Person

Patents Grantslast 30 patents

α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors

Compounds for the treatment of hepatitis C

Compounds for the treatment of hepatitis C

α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors

Compounds for the treatment of hepatitis C

Compounds for the treatment of hepatitis C

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

Indolobenzazepine HCV NS5B inhibitors

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

HCV NS5B inhibitors

Inhibitors of HCV replication

α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors

Inhibitors of HCV replication

Sulfonamide compounds and uses thereof

Patents Applicationslast 30 patents

Alpha-(N-Sulfonamido)Acetamide Derivatives as Beta-Amyloid Inhibitors

Compounds for the Treatment of Hepatitis C

Compounds for the Treatment of Hepatitis C

Compounds for the Treatment of Hepatitis C

Compounds for the Treatment of Hepatitis C

ALPHA-(N-SULFONAMIDO)ACETAMIDE DERIVATIVES AS BETA-AMYLOID INHIBITORS

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

HCV NS5B Inhibitors

Indolobenzazepine HCV NS5B inhibitors

Inhibitors of HCV replication

Inhibitors of HCV replication

Alpha-(N-sulfonamido)acetamide derivatives as beta-amyloid inhibitors